Bissinger Ron 4
4 · ALPHA INNOTECH CORP · Filed Oct 29, 2009
Insider Transaction Report
Form 4
ALPHA INNOTECH CORPAPNO.OB
Bissinger Ron
DirectorCEO & COO
Transactions
- Disposition to Issuer
Common Stock
2009-10-28−180,000→ 0 total - Disposition to Issuer
Stock Option (Right to Buy)
2009-10-28$0.62/sh−100,000$62,000→ 0 totalExercise: $0.88Exp: 2019-09-01→ Common Stock (100,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2009-10-28−200,000→ 0 totalExercise: $1.53Exp: 2016-04-09→ Common Stock (200,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2009-10-28$0.60/sh−45,000$27,000→ 0 totalExercise: $0.90Exp: 2017-02-13→ Common Stock (45,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2009-10-28$0.52/sh−100,000$52,000→ 0 totalExercise: $0.98Exp: 2018-06-16→ Common Stock (100,000 underlying)
Footnotes (5)
- [F1]Disposed of pursuant to a merger agreement between the Issuer and Cell Biosciences, Inc. in exchange for a cash payment of $1.50 per share on the effective date of the merger.
- [F2]This option, which provided for vesting at the rate of 25% after one year and monthly vesting of the remainder in equal installments over the following three years, was canceled on the effective date of the merger.
- [F3]This option, which provided for vesting at the rate of 25% after one year and monthly vesting of the remainder in equal installments over the following three years, was canceled in the merger in exchange for a cash payment of $27,000, representing the difference between the exercise price of the option and the merger price ($1.50 per share).
- [F4]This option, which provided for monthly vesting in equal installments over four years, was canceled in the merger in exchange for a cash payment of $52,000, representing the difference between the exercise price of the option and the merger price ($1.50 per share).
- [F5]This option, which provided for vesting at the rate of 25% after one year and monthly vesting of the remainder in equal installments over the following three years, was canceled in the merger in exchange for a cash payment of $62,000, representing the difference between the exercise price of the option and the merger price ($1.50 per share).